Lidocaine alleviates inflammation and pruritus in atopic dermatitis by blocking different population of sensory neurons
British Journal of Pharmacology · 2023-05 · 180 (10) · 1339-1361
DOI: 10.1111/bph.16012 ↗At a glance
Journal article in British Journal of Pharmacology, published online on 2023-01-08. Written by Pei-Yi Sun and 18 co-authors. Institution: Department of Dermatology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, China. Major MEDLINE topics: Dermatitis, Atopic. Cited 27 times so far (Crossref); 106 references. Funded by: National Natural Science Foundation of China, Innovative Research Team of High-level Local University in Shanghai.
Abstract (original language)
Background and Purpose Atopic dermatitis is a common chronic pruritic inflammatory disease of the skin involving neuro‐immune communication. Neuronal mechanism‐based therapeutic treatments remain lacking. We investigated the efficacy of intravenous lidocaine therapy on atopic dermatitis and the underlying neuro‐immune mechanism. Experimental Approach Pharmacological intervention, immunofluorescence, RNA‐sequencing, genetic modification and immunoassay were performed to dissect the neuro‐immune basis of itch and inflammation in atopic dermatitis‐like mouse model and in patients. Key Results Lidocaine alleviated skin lesions and itch in both atopic dermatitis patients and calcipotriol (MC903)‐induced atopic dermatitis model by blocking subpopulation of sensory neurons. QX‐314, a charged Na V blocker that enters through pathologically activated large‐pore ion channels and selectivity inhibits a subpopulation of sensory neurons, has the same effects as lidocaine in atopic dermatitis model. Genetic silencing Na V 1.8‐expressing sensory neurons was sufficient to restrict cutaneous inflammation and itch in the atopic dermatitis model. However, pharmacological blockade of TRPV1‐positive nociceptors only abolished persistent itch but did not affect skin inflammation in the atopic dermatitis model, indicating a difference between sensory neuronal modulation of skin inflammation and itch. Inhibition of activity‐dependent release of calcitonin gene‐related peptide (CGRP) from sensory neurons by lidocaine largely accounts for the therapeutic effect of lidocaine in the atopic dermatitis model. Conclusion and Implications Na V 1.8 + sensory neurons play a critical role in pathogenesis of atopic dermatitis and lidocaine is a potential anti‐inflammatory and anti‐pruritic agent for atopic dermatitis. A dissociable difference for sensory neuronal modulation of skin inflammation and itch contributes to further understanding of pathogenesis in atopic dermatitis.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Dermatology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, China.
- Institute of Dermatology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, China.
- Centre for Brain Science of Shanghai Children's Medical Centre, Department of Anatomy and Physiology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
- Department of Rehabilitation Medicine, Huashan Hospital, Institute for Translational Brain Research, State Key Laboratory of Medical Neurobiology and Ministry of Education Frontiers Centre for Brain Science, Fudan Unive…
ORCID profiles: Wei-Guang Li
Funding
- National Natural Science Foundation of China
- Innovative Research Team of High-level Local University in Shanghai
Cite
APA
Sun, P. Y., Li, H. G., Xu, Q. Y., Zhang, Z., Chen, J. W., Shen, Y. H., Qi, X., Lu, J. F., Tan, Y. D., Wang, X. X., Li, C. X., Yang, M. Y., Ma, Y. Z., Lu, Y., Xu, T. L., Shen, J. W., Li, W. G., Guo, Y. F., & Yao, Z. R. (2023). Lidocaine alleviates inflammation and pruritus in atopic dermatitis by blocking different population of sensory neurons. British Journal of Pharmacology, 180(10), 1339-1361. https://doi.org/10.1111/bph.16012
Vancouver
Sun PY, Li HG, Xu QY, Zhang Z, Chen JW, Shen YH, et al. Lidocaine alleviates inflammation and pruritus in atopic dermatitis by blocking different population of sensory neurons. British Journal of Pharmacology. 2023;180(10):1339-1361. doi:10.1111/bph.16012
BibTeX
@article{Sun2023,
author = {Sun, Pei-Yi and Li, Hua-Guo and Xu, Qian-Yue and Zhang, Zhen and Chen, Jia-Wen and Shen, Yi-Hang and Qi, Xin and Lu, Jian-Fei and Tan, Yi-Dong and Wang, Xiao-Xiao and Li, Chun-Xiao and Yang, Meng-Ying and Ma, Yu-Zhi and Lu, Ying and Xu, Tian-Le and Shen, Jin-Wen and Li, Wei-Guang and Guo, Yi-Feng and Yao, Zhi-Rong},
title = {Lidocaine alleviates inflammation and pruritus in atopic dermatitis by blocking different population of sensory neurons},
journal = {British Journal of Pharmacology},
year = {2023},
volume = {180},
number = {10},
pages = {1339--1361},
doi = {10.1111/bph.16012}
}
EUVIMED